Investors & Media


Altamira Therapeutics is dedicated to developing therapeutics that address important unmet medical needs. The Company is currently active in RNA therapeutics, allergy and viral infections, and inner ear disorders. The Company was founded in 2003 and is headquartered in Hamilton, Bermuda with its main operations in Basel, Switzerland. The shares of Altamira Therapeutics Ltd. trade on the NASDAQ Capital Market under the symbol “CYTO.”

Upcoming Events

There are currently no upcoming events at this time. Please check again later.

Investor Contact

Primary IR Contacts

Thomas Meyer
Chairman and CEO

Altamira Therapeutics Ltd.

Stock Quote


Recent Press Releases